AG
OVID icon

Artal Group’s Ovid Therapeutics OVID Stock Holding History

Artal Group’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,500,000
Closed -$1.92M – 65
2024
Q2 		$1.92M Hold
2,500,000
– – 0.05% 77
2024
Q1 		$7.63M Hold
2,500,000
– – 0.2% 52
2023
Q4 		$8.05M Hold
2,500,000
– – 0.27% 40
2023
Q3 		$9.6M Hold
2,500,000
– – 0.42% 38
2023
Q2 		$8.2M Hold
2,500,000
– – 0.26% 56
2023
Q1 		$6.45M Hold
2,500,000
– – 0.38% 55
2022
Q4 		$4.65M Hold
2,500,000
– – 0.27% 65
2022
Q3 		$4.6M Hold
2,500,000
– – 0.24% 63
2022
Q2 		$5.38M Hold
2,500,000
– – 0.3% 56
2022
Q1 		$7.85M Hold
2,500,000
– – 0.33% 60
2021
Q4 		$8.03M Hold
2,500,000
– – 0.24% 78
2021
Q3 		$8.4M Hold
2,500,000
– – 0.21% 89
2021
Q2 		$9.78M Hold
2,500,000
– – 0.22% 90
2021
Q1 		$10.1M Hold
2,500,000
– – 0.21% 98
2020
Q4 		$5.78M Hold
2,500,000
– – 0.13% 103
2020
Q3 		$14.3M Buy
+2,500,000
New +$16.7M 0.47% 62

Other funds holding OVID

TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return